Arcadia Biosciences, Inc. (RKDA)

NASDAQ: RKDA · Real-Time Price · USD
1.080
+0.010 (0.93%)
At close: Apr 27, 2026, 4:00 PM EDT
1.081
+0.001 (0.06%)
After-hours: Apr 27, 2026, 7:02 PM EDT
Market Cap2.22M -44.5%
Revenue (ttm)4.86M -3.7%
Net Income-2.34M
EPS-1.71
Shares Out 2.06M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume9,524
Open1.160
Previous Close1.070
Day's Range1.080 - 1.160
52-Week Range0.890 - 6.710
Beta0.72
Analystsn/a
Price Targetn/a
Earnings DateMay 7, 2026

About RKDA

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

IPO Date May 15, 2015
Employees 8
Stock Exchange NASDAQ
Ticker Symbol RKDA
Full Company Profile

Financial Performance

In 2025, Arcadia Biosciences's revenue was $4.86 million, a decrease of -3.71% compared to the previous year's $5.05 million. Losses were -$2.34 million, -66.77% less than in 2024.

Financial Statements

News

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2025 Financial Results and Business Highlights

-- Zola ® revenues increase 17% year-over-year -- -- Arcadia and Roosevelt Resources terminate proposed business combination --

4 weeks ago - GlobeNewsWire

Arcadia Biosciences (RKDA) Announces Exercise of Preferred Investment Options for $2.1 Million Gross Proceeds

DALLAS, Jan. 12, 2026 (GLOBE NEWSWIRE) --  Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that it has entered into definitive agre...

3 months ago - GlobeNewsWire

Arcadia Biosciences (RKDA) Receives Termination Notice of the Proposed Business Combination with Roosevelt Resources

DALLAS, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Arcadia Biosciences, Inc .® (Nasdaq: RKDA), a producer and marketer of innovative wellness products, today announced that on December 24, 2025, it received a ...

4 months ago - GlobeNewsWire

Arcadia Biosciences (RKDA) Announces Third Quarter 2025 Financial Results and Business Highlights

-- Zola ® year-to-date revenues increase 26% year over year -- -- Arcadia gross profit margins exceed 30% for 11 th straight quarter -- -- Arcadia cash balance declines by only $257K to $1.1M -- DALLA...

6 months ago - GlobeNewsWire

Soybean Short Squeeze: Cooking Oil Stocks Pop After Trump Targets China

Soybean-related stocks exploded on Wednesday following President Donald Trump's latest comments in the ongoing trade war with China.

Other symbols: CBUSCOOTPFAISDOTSEED
6 months ago - Benzinga

Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2025 Financial Results and Business Highlights

-- Arcadia revenues increase 11% year over year driven by 24% growth in Zola ® -- -- Arcadia receives 2.7 million shares of stock in ABVE --

9 months ago - GlobeNewsWire

Arcadia Biosciences Earnings Call Transcript: Q1 2025

Zola sales surged 90% year-over-year in Q1 2025, outpacing the coconut water category and driving a 22% revenue increase. The company exited its legacy agtech business, monetized IP, and reduced liabilities, while the Roosevelt Resources merger remains on track for completion by August.

1 year ago - Transcripts

Arcadia Biosciences (RKDA) Announces First Quarter 2025 Financial Results and Business Highlights

-- Revenues increase 22% year over year driven by 90% growth in Zola ® -- -- Arcadia sells patents for $750K and eliminates $1M in liabilities -- -- Roosevelt agreement amended to provide greater cert...

1 year ago - GlobeNewsWire

Arcadia Biosciences (RKDA) Announces Date of First Quarter 2025 Financial Results and Business Highlights Conference Call

Arcadia Biosciences, Inc.® (Nasdaq: RKDA) will release its financial and business results for the first quarter of 2025 on May 8, 2025 at 2:00 p.m. ET.

1 year ago - GlobeNewsWire

Arcadia Biosciences Earnings Call Transcript: Q4 2024

2024 saw a strategic refocus on Zola coconut water, driving 46% sales growth and record distribution gains, while exiting underperforming brands and monetizing legacy assets. Gross margins remained strong, and the Roosevelt Resources transaction is expected to close by Q2 2025.

1 year ago - Transcripts

Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2024 Financial Results and Business Highlights

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results f...

1 year ago - Business Wire

Arcadia Biosciences (RKDA) Announces Date of Fourth Quarter 2024 Financial Results and Business Highlights Conference Call

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial ...

1 year ago - Business Wire

Arcadia Biosciences Transcript: M&A Announcement

Arcadia will issue shares to acquire Roosevelt, resulting in Roosevelt owning 90% of the combined entity. The deal enables Roosevelt to advance its large-scale CCUS and EOR project, with the company renamed Roosevelt Resources and led by Roosevelt’s management.

1 year ago - Transcripts

ARCADIA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Arcadia Biosciences, Inc. - RKDA

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Arcadia Biosci...

1 year ago - Business Wire

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Arcadia Biosciences, Inc.

NEW YORK , Dec. 6, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Arcadia Biosciences, Inc. (NASDAQ: RKDA) and its board of directors concerning the propo...

1 year ago - PRNewsWire

Arcadia Biosciences (RKDA) Enters Into Business Combination Agreement with Roosevelt Resources in All-Stock Transaction

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA) and Roosevelt Resources LP announced today that they have entered into a definitive securities exchange agreement which, when complet...

1 year ago - Business Wire

Arcadia Biosciences Earnings Call Transcript: Q3 2024

Q3 2024 saw 18% revenue growth, led by a 55% increase in Zola sales and major distribution gains. Cash burn hit historic lows, and Zola outpaced the coconut water category, with new product launches planned for next year.

1 year ago - Transcripts

Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2024 Financial Results and Business Highlights

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results f...

1 year ago - Business Wire

Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2024 Financial Results and Business Highlights Conference Call

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial ...

1 year ago - Business Wire

Arcadia Biosciences Earnings Call Transcript: Q2 2024

Q2 2024 marked a strategic shift, with wheat IP monetization and GoodWheat exit fueling cost savings and a focus on Zola Coconut Water, which saw 42% sales growth. Revenues are expected to match 2023, with gross margins in the low 40s and cash burn halved.

1 year ago - Transcripts

Arcadia Biosciences (RKDA) Announces Second-Quarter and First-Half 2024 Financial Results and Business Highlights

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results f...

1 year ago - Business Wire

Prime Therapeutics Fails to Silence AHF in PBM Price-Fixing Arbitration

LOS ANGELES--(BUSINESS WIRE)--Prime Therapeutics Fails to Silence AHF in PBM Price-Fixing Arbitration.

Other symbols: VRTX
1 year ago - Business Wire

Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2024 Financial Results and Business Highlights Conference Call

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial ...

1 year ago - Business Wire

The Cheesecake Factory Offers Triple the Reasons to Celebrate National Cheesecake Day This Year

CALABASAS HILLS, Calif.--(BUSINESS WIRE)--The Cheesecake Factory® is celebrating its favorite holiday – National Cheesecake Day – in a big way this year making it a two-day celebration and introducing...

Other symbols: CNK
1 year ago - Business Wire

Arcadia Biosciences (RKDA) Announces Leadership Transition

DALLAS--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced that CEO Stan Jacot has left the company ...

1 year ago - Business Wire